K-PAX is interested in working with partners to support the further development of KPAX002.

Questions regarding investment opportunities can be directed to K-PAX Pharmaceuticals' Director of Operations, Anne Lahaderne at: This email address is being protected from spambots. You need JavaScript enabled to view it. or by calling (415) 381-7655.